Emergent BioSolutions (EBS) Reports Financial Results For Second Quarter And First Six Months Of 2014
8/8/2014 9:10:30 AM
Emergent BioSolutions Inc. (NYSE: EBS) reported total revenue for Q2 2014 of $110.3 million as compared to $82.4 million in 2013. Total revenues for the first six months of 2014 were $164.2 million as compared to $125.5 million in 2013. The company is increasing its full year 2014 total revenue forecast to $425 to $450 million, from $415 to $445 million. The company also anticipates Q3 2014 total revenue of $110 to $125 million.
Help employers find you! Check out all the jobs and post your resume.
comments powered by